If you gather together any group of people and ask about medical experiences, you will inevitably hear stories of friends or family members who experienced exceptionally aggressive care only to die shortly thereafter. The question that so often follows is “Why?”. Why did they die, despite such aggressive treatment? Why didn’t the treatment work? Why did they have to endure such pain? Why didn’t I know that they were so close to death?
This accredited education session will help you, your patients and families answer this question.
Your Home Health Agency will be surveyed soon. With all the changes that are constant in the world of Home Health, one thing that does not change is the importance of preparing well for a surveyor to walk through your door - especially with new Conditions of Participation and outcome-driven care now the norm. How to prepare for and perform well in your next Survey should not be a secret.
In this episode, I get to the bottom of Pre-Claim Review, and the "new" version of PCR called Review Choice Demonstration, thanks to Aaron Little of BKD. This new podcast episode goes really in depth on the origin of PCR, and how it ultimately came to its end. It also sheds light on what to expect with the resurrected version!
There is a myth in the Post-Acute Care market that Hospice agencies have less to worry about than their Home Health brethren. This is false. One area of constant struggle for Hospice agencies is improving their patients’ Length of Stay. This webinar will teach how to use your data to increase your hospice’s length of stay while promoting early referrals and ensuring your patients receive the maximum benefit.
After a long absence, the So What, Who Cares? podcast is back with John Griscavage of PlayMaker Health. We discuss his dynamic organization: What they do, why they acquired ViaDirect, and how they can impact growth in the post-acute health care market.
In this "InBoxing" article, Aaron Little of BKD discusses (the artist formerly known as) Pre-Claim Review. The Medicare home health pre-claim review (PCR) process implemented in 2016 created extensive operational challenges and payment delays and was eventually “paused” in 2017. A new threat to operational efficiency and cash flow has been proposed to replace PCR in the form of the Review Choice Demonstration (RCD).
Aaron and I discuss why it has resurfaced, what has changed, what will be different this time around, and a new name for this significant regulatory change.